Filing Details

Accession Number:
0001562180-24-002258
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 16:22:50
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 16:22:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1568651 Oscar Health Inc. OSCR Hospital & Medical Service Plans (6324) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1911946 Victoria Baltrus 75 Varick Street, 5Th Floor
New York City NY 10013
Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-03-01 4,121 $0.00 63,864 No 4 M Direct
Class A Common Stock Acquisiton 2024-03-01 4,811 $0.00 68,675 No 4 M Direct
Class A Common Stock Acquisiton 2024-03-01 7,500 $0.00 76,175 No 4 M Direct
Class A Common Stock Acquisiton 2024-03-01 75,643 $0.00 151,818 No 4 A Direct
Class A Common Stock Disposition 2024-03-04 33,707 $15.88 118,111 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Restricted Stock Units Disposition 2024-03-01 4,121 $0.00 4,121 $0.00
Class A Common Stock Restricted Stock Units Disposition 2024-03-01 4,811 $0.00 4,811 $0.00
Class A Common Stock Restricted Stock Units Disposition 2024-03-01 7,500 $0.00 7,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,481 No 4 M Direct
28,865 No 4 M Direct
59,997 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
  2. The Issuer previously granted the Reporting Person an award of 75,643 restricted stock units that vested on March 1, 2024, following the Compensation Committee's determination that the performance condition for the prior fiscal year had been achieved.
  3. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.76 to $16.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  5. The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2022.
  6. The restricted stock units vested with respect to 25% of the shares on September 1, 2022, and will vest with respect to the remaining shares in 12 equal quarterly installments thereafter.
  7. The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2023.